CSI Market
Sign In | Register

Nasus Pharma Ltd (NSRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access NSRX quarterly Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Nasus Pharma Ltd manages its resources, obligations, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
Assets
Cash & cash equivalent1.24
Deposits Assets, Current AS3.05
Cash & Short-term Investments4.00
Other Current Assets0.05
Prepaid Expense And Other Assets Current0.52
Total Current Assets4.86
Equipment/Property/Plant Net0.01
Tax Assets, Noncurrent3.34
Other Assets, Noncurrent0.14
Restricted Cash0.05
Operating Lease Right Of Use Asset0.14
Total Assets5.00
Liabilities
Accounts Payable, Current AC0.81
Accrued Liabilities, Current0.55
Other Liabilities, Current0.85
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.16
Total Current Liabilities2.16
Total Long-term Debt0.00
Other liabilities, Noncurrent0.07
OperatingLeaseLiabilityNoncurrent0.07
Operating Lease Liability Current0.05
Total Liabilities2.24
Stockholders' Equity
Additional Paid In Capital Common Stock21.29
Retained Earnings / Accumulated Deficit-18.52
Common Stockholder's Equity2.77
Total Stockholder's Equity2.77
Liabilities & Stockholder's Equity5.00
4 historic quarters locked

Sign in to unlock the full Nasus Pharma Ltd balance sheet history.

Sign In Create Free Account

About Nasus Pharma Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: March 25, 2026
  • Source: form20-f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-012559

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI